Related references
Note: Only part of the references are listed.Natural History of Drusenoid Pigment Epithelial Detachment in Age-Related Macular Degeneration: Age-Related Eye Disease Study Report No. 28
Catherine Cukras et al.
OPHTHALMOLOGY (2010)
Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate
Ruth Arnon et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Molecular mechanisms of mTOR-mediated translational control
Xiaoju Max Ma et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
A Phase I Study of Intravitreal Vascular Endothelial Growth Factor Trap-Eye in Patients with Neovascular Age-Related Macular Degeneration
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2009)
Cardiovascular Risk and Antiangiogenic Therapy for Age-related Macular Degeneration
Jose Tunon et al.
SURVEY OF OPHTHALMOLOGY (2009)
The natural history and prognosis of neovascular age-related macular degeneration
Tien Wong et al.
OPHTHALMOLOGY (2008)
Integrins in angiogenesis and lymphangiogenesis
Christie J. Avraamides et al.
NATURE REVIEWS CANCER (2008)
Genotype-phenotype correlations for exudative age-related macular degeneration associated with homozygous HTRA1 and CFH genotypes
Nicolas Leveziel et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab
Milam A. Brantley et al.
OPHTHALMOLOGY (2007)
Complement C3 variant and the risk of age-related macular degeneration
John R. W. Yates et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cigarette smoking and age-related macular degeneration in the EUREYE study
U. Chakravarthy et al.
OPHTHALMOLOGY (2007)
Triple therapy for choroidal neovascularization due to agerelated macular degeneration - Verteporfin PDT, bevacimmab, and dexamethasone
Albert J. Augustin et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2007)
HTRA1 promoter polymorphism in wet age-related macular degeneration
Andrew DeWan et al.
SCIENCE (2006)
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration - Year 1 results of the FOCUS study
Jeffrey S. Heier et al.
ARCHIVES OF OPHTHALMOLOGY (2006)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration
Anne E. Hughes et al.
NATURE GENETICS (2006)
Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration
B Gold et al.
NATURE GENETICS (2006)
Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation
JC Khan et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk
A Rivera et al.
HUMAN MOLECULAR GENETICS (2005)
Meta-analysis of genome scans of age-related macular degeneration
SA Fisher et al.
HUMAN MOLECULAR GENETICS (2005)
Complement factor H polymorphism and age-related macular degeneration
AO Edwards et al.
SCIENCE (2005)
Complement factor H variant increases the risk of age-related macular degeneration
JL Haines et al.
SCIENCE (2005)
Angiogenesis - Where do we stand now?
M Simons
CIRCULATION (2005)
Preclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administration
J Gaudreault et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Smoking and age-related macular degeneration: a review of association
J Thornton et al.
EYE (2005)
VEGF164(165) as the pathological isoform:: Differential leukocyte and endothelial responses through VEGFR1 and VEGFR2
T Usui et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization
JM Rakic et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?
CG Owen et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2003)
Oxidants, oxidative stress and the biology of ageing
T Finkel et al.
NATURE (2000)
Share Paper
